Pathstone Holdings’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.86M Sell
60,071
-8,581
-12% -$564K 0.01% 775
2026
Q1
$4.89M Sell
68,652
-925
-1% -$72.9K 0.02% 578
2025
Q4
$5.71M Buy
69,577
+32,712
+89% +$2.55M 0.02% 517
2025
Q3
$2.77M Buy
36,865
+654
+2% +$48.8K 0.01% 851
2025
Q2
$2.68M Sell
36,211
-1,358
-4% -$94.5K 0.01% 834
2025
Q1
$3.02M Buy
37,569
+1,999
+6% +$172K 0.01% 761
2024
Q4
$2.78M Buy
35,570
+1,750
+5% +$149K 0.01% 804
2024
Q3
$3.17M Buy
33,820
+1,063
+3% +$89.2K 0.01% 739
2024
Q2
$2.55M Sell
32,757
-622
-2% -$50.7K 0.01% 806
2024
Q1
$3.03M Buy
33,379
+1
+0% +$83 0.01% 717
2023
Q4
$2.58M Buy
+33,378
New +$2.34M 0.01% 650

Other funds holding GEHC

Pathstone Holdings's GEHC Position: Q2 2026 in Review

Pathstone Holdings reduced its GE HealthCare (GEHC) stake by 12% in Q2 2026, selling an estimated $564K and leaving 60,071 shares worth $3.86M. The position accounts for 0.01% of the portfolio, ranked #775.

Pathstone Holdings first reported a position in GEHC in Q4 2023 and has held it in 11 quarters since. The position peaked at $5.71M in Q4 2025. 1,233 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Pathstone Holdings held 60,071 shares of GE HealthCare worth $3.86M as of Q2 2026.
  • Pathstone Holdings sold 8,581 GE HealthCare shares in Q2 2026, an estimated $564K.
  • GE HealthCare made up 0.01% of Pathstone Holdings's portfolio in Q2 2026, its #775 holding.
  • Pathstone Holdings first reported a position in GE HealthCare in Q4 2023 and has held it in 11 quarters since.
  • Pathstone Holdings's GE HealthCare position peaked at $5.71M in Q4 2025.
  • 1,233 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.